Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sarilumab
Sarilumab
FDA Approves Regeneron-Sanofi's Sarilumab As First Biologic For Stiffness, Pain In Muscles
FDA Approves Regeneron-Sanofi's Sarilumab As First Biologic For Stiffness, Pain In Muscles
Yahoo/Benzinga
Regeneron
Sanofi
FDA
Kevzara
Sarilumab
polymyalgia rheumatica
Flag link:
EMA panel recommends nod for Sanofi, Regeneron's arthritis drug
EMA panel recommends nod for Sanofi, Regeneron's arthritis drug
Yahoo/Reuters
Europe
EMA
Sanofi
Regeneron
rheumatoid arthritis
Kevzara
Sarilumab
Flag link:
Regeneron, Sanofi Drug Delayed by Plant Snag
Regeneron, Sanofi Drug Delayed by Plant Snag
Investopedia
Regeneron
Sanofi
Dupixent
drug manufacturing
Sarilumab
Flag link:
FDA approval could be delayed for Sanofi Genzyme’s next blockbuster
FDA approval could be delayed for Sanofi Genzyme’s next blockbuster
Bizjournals.com
FDA
Sanofi
Sanofi Genzyme
drug manufacturing
biosimilars
Humira
Sarilumab
Flag link:
3 Critical FDA Decisions You Can't Afford to Miss
3 Critical FDA Decisions You Can't Afford to Miss
Motley Fool
FDA
Orkambi
Vertex Pharmaceuticals
Roche
Tecentriq
Regeneron
Sanofi
Sarilumab
Flag link:
FDA set to decide on two likely blockbuster drugs by Sanofi Genzyme
FDA set to decide on two likely blockbuster drugs by Sanofi Genzyme
Bizjournals.com
FDA
Sanofi Genzyme
Regeneron
Sarilumab
dupilumab
eczema
rheumatoid arthritis
Flag link:
Should AbbVie Fear Sanofi-Regeneron Drug Trial Data?
Should AbbVie Fear Sanofi-Regeneron Drug Trial Data?
Bidness, ETC
AbbVie
Sanofi
Regeneron
clinical trials
Sarilumab
Humira
biosimilars
rheumatoid arthritis
Flag link:
Sanofi Drug Beats AbbVie's Blockbuster Humira in Human Trial
Sanofi Drug Beats AbbVie's Blockbuster Humira in Human Trial
Bloomberg
Sanofi
AbbVie
Humira
clinical trials
Sarilumab
rheumatoid arthritis
Flag link:
Sanofi and Regeneron Hit Another Bullseye
Sanofi and Regeneron Hit Another Bullseye
Motley Fool
Sanofi
Regeneron
rheumatoid arthritis
Sarilumab
Flag link:
Regeneron's arthritis drug nails it in phase III
Regeneron's arthritis drug nails it in phase III
BioPharma Dive
Regeneron
Sarilumab
rheumatoid arthritis
Flag link:
Sanofi, Regeneron announce new data from positive sarilumab Phase 3 trial
Sanofi, Regeneron announce new data from positive sarilumab Phase 3 trial
The Fly on the Wall
Sanofi
Regeneron
Sarilumab
rheumatoid arthritis
Flag link:
Sanofi Rheumatoid Arthritis Drug Reduces Pain, Damage in Study
Sanofi Rheumatoid Arthritis Drug Reduces Pain, Damage in Study
Bloomberg
Sanofi
Regeneron
rheumatoid arthritis
Sarilumab
Flag link:
What's in Regeneron's Pipes?
What's in Regeneron's Pipes?
Motley Fool
Regeneron
Sanofi
REGN688
Eylea
Sarilumab
Flag link:
Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis
Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis
Yahoo
Regeneron
Sanofi
Sarilumab
rheumatoid arthritis
ankylosing spondylitis
Flag link: